Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1506161
                    [Title] => Antibiotic pinababawi ng FDA
                    [Summary] => 
Pinababawi ng Food and Drugs Administration (FDA) sa merkado ng ilang batch ng isang antibiotic matapos hindi makasunod sa tamang specifications.

                    [DatePublished] => 2015-10-01 10:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1096851
                    [AuthorName] =>  Doris Franche-Borja
                    [SectionName] => Bansa
                    [SectionUrl] => bansa
                    [URL] => 
                )

        )

)

ANG RIFAMPICIN SUSPENSION

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1506161
                    [Title] => Antibiotic pinababawi ng FDA
                    [Summary] => 
Pinababawi ng Food and Drugs Administration (FDA) sa merkado ng ilang batch ng isang antibiotic matapos hindi makasunod sa tamang specifications.

                    [DatePublished] => 2015-10-01 10:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1096851
                    [AuthorName] =>  Doris Franche-Borja
                    [SectionName] => Bansa
                    [SectionUrl] => bansa
                    [URL] => 
                )

        )

)

abtest

Antibiotic pinababawi ng FDA

By Doris Franche-Borja | October 1, 2015 - 10:00am

Pinababawi ng Food and Drugs Administration (FDA) sa merkado ng ilang batch ng isang antibiotic matapos hindi makasunod sa tamang specifications.

Bansa